Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR01Clinical trial: Not allowed

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-322

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Aug 25, 2028
Letter of intent
Mechanism
R01
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Aug 25, 2025
Total funding
Clinical trial
Not allowed
Early careerSmall businessGovernmentHigher educationNonprofitForeign entities

Funding context

16%of applications funded

Based on FY2024 NIH (all institutes) R01 applications (5,385 of 33,139 applications awarded).

Institute-specific data wasn’t available — showing the NIH-wide rate for this mechanism.

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIH-wide R01, all institutes.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Research areas

Training & career development

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.